Impact Factor
3.74
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.83
1,416 total citations
h5-index
42
h5 depth signal
Cited share
72.1%
279 of 387
Total citations
1,416
Citation footprint
Metric signal
3.38
External metric anchor
Self-citation
0.8%
12 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
3,557
Japan
364
United States
248
South Korea
223
Italy
71
Citing Fields of Research
Cancer & Development
1,482
Noncoding RNA
1,160
Oncology
1,082
Cancer, Autophagy & Apoptosis
1,073
Liver & Colon Cancer
638
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
13,629
Articles tracked across the journal lifetime
Indexed publication set
387
279 cited publications
Last 12 months
203
16.9 publications/month
Open access share
94.6%
192 OA publications in the last year
Leading citing country
China
3,557 citing publications
Leading citing field
Cancer & Development
1,482 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v5n1, 1998-
v5n1, 1998-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cancer, Autophagy & Apoptosis
Oncology
Cancer & Development
Lung Cancer
Immunology
Noncoding RNA
Issuing & Sponsoring Bodies
Contributor
Ethnikon Hidryma Ereunōn (Greece)
Broad Categories
Neoplasms
Noncoding RNA
Cancer, Autophagy & Apoptosis
Cancer & Development
Immunotherapy
Cell Biology
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.3892/or.2026.9213
Open DOI
CHCHD2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma: Insights from pan‑cancer multi‑omics and functional studies
Lung adenocarcinoma (LUAD) remains a leading cause of cancer‑related mortality, and mitochondrial proteins have been increasingly implicated in tumor progression. Coiled‑coil‑helix‑coiled‑coil‑helix domain‑containing 2 (CHCHD2) has been ...
02
DOI 10.3892/or.2026.9212
Open DOI
PBRM1 knockdown is associated with NRF2‑dependent ALDOA upregulation and metabolic reprogramming in HCCC‑9810 intrahepatic cholangiocarcinoma cells
Polybromo‑1 (PBRM1) is a chromatin‑remodeling factor that is altered in intrahepatic cholangiocarcinoma (ICC). The present study examined the effects of PBRM1 knockdown on tumor‑related phenotypes and glucose metabolism in HCCC‑9810 ICC ...
03
DOI 10.3892/or.2026.9211
Open DOI
SEC31A promotes gastric cancer progression by inducing the PI3K/AKT/mTOR pathway and enhancing the CCL5‑mediated M2 polarization and recruitment of tumor‑associated macrophages
SEC31 homolog A (SEC31A) is associated with a variety of cancers. This study elucidated the role of SEC31A in gastric cancer (GC). The expression of SEC31A in GC was analyzed using western blotting and immunohistochemistry. Functional ex...
04
DOI 10.3892/or.2026.9210
Open DOI
Advances in neoadjuvant therapy for locally advanced head and neck squamous cell carcinoma (Review)
The majority of head and neck cancers arise from the mucosal squamous epithelium of the oral cavity, pharynx and larynx, and are collectively referred to as head and neck squamous cell carcinoma (HNSCC). A multimodal standard of care is ...
05
DOI 10.3892/or.2026.9209
Open DOI
miR‑324‑5p in oncology: Molecular mechanisms and clinical outlook (Review)
MicroRNAs (miRNAs or miRs) represent a class of regulatory non‑coding RNAs that control post‑transcriptional gene expression and influence multiple cancer‑associated biological processes. Among these molecules, miR‑324‑5p exhibits cancer...
06
DOI 10.3892/or.2026.9208
Open DOI
PRMT7 at the crossroads of cancer progression and therapeutic targeting (Review)
Protein arginine methyltransferase 7 (PRMT7), the sole type III PRMT family member, catalyzes arginine monomethylation and has recently emerged as an important regulator of cancer biology. Increasing evidence indicates that PRMT7 partici...
07
DOI 10.3892/or.2026.9207
Open DOI
[Retracted] miR‑29a inhibits human retinoblastoma progression by targeting STAT3
Following the publication of this paper, and a corrigendum (doi: 10.3892/or.2017.6144) published in 2021 to take account of duplicated western blot data that were identified in Fig. 4D, it has subsequently come to light that flow cytomet...
08
DOI 10.3892/or.2026.9206
Open DOI
Expression of V‑domain Ig suppressor of T cell activation in ovarian cancer and its regulation of follicular regulatory T‑cell function via the AKT/MAPK pathway
The high mortality associated with ovarian cancer is closely linked to immune remodeling within the tumor microenvironment (TME). V‑domain Ig suppressor of T cell activation (VISTA), a novel immune checkpoint, has attracted increasing at...
09
DOI 10.3892/or.2026.9205
Open DOI
[Expression of Concern] ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer
Following the publication of the above article, a concerned reader has contacted the Editorial Office to draw attention to the fact that there appeared to be discrepancies between the numbers of patients reported with low‑ or high‑ZNF703...
10
DOI 10.3892/or.2026.9203
Open DOI
Loperamide enhances the radiosensitivity of cervical cancer cells via ferroptosis induction
Cervical cancer is a malignant tumor that threatens women's health and radiotherapy represents a major therapeutic approach for its treatment; however, radioresistance frequently leads to treatment failure. The present study aimed to inv...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 44 (2020).
Also issued online.
Vol. 1, no. 1 (1994)19980219 Notice published Printed on acid-free paper